Search
for
Sort by
Research 661–690 of 1000+
- Some skin affection in New Valley Governorate
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- 713 Fisetin promotes differentiation, inhibits proliferative and inflammatory responses in cultured human cells and alleviates psoriasiform dermatitis in mice
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- 709 Nitric oxide-releasing topical therapeutic agent for atopic dermatitis
- Efficacy of Betamethasone Oral Mini-Pulse Therapy in the Treatment of Lichen Planus
- Anhidrotic effect of intradermal injections of botulinum toxin—A comparison of different products and concentrations
- Trilostane Treatment of Canine Alopecia X in an American Pit Bull Terrier
- Thyroxin Levels and Haematological changes in Dogs with Sarcoptic Mange
- Thermographic Follow-up of a Mild Case of Herpes Zoster
- Clinical description of a rare dermatological disease, acne Keloidalis Nuchae, and successful homoeopathic management: A case report
- Haematobiochemical Alterations in Rabbit Mange
- Mange Infestation and its Successful Treatment in Rabbits
- Parasitic Perifollicular Dermatitis in the Egyptian Lesser Blind Mole Rat (<i>Spalax leucodon egyptiacus</i>)
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products
- Physiological and biological skin changes in pregnancy
- Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Diagnosis and Management of Alopecia in Children
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Psychocutaneous disease
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations